Zdrowie i gospodarka · 28/11/2011
FDA Clears Docetaxel Injection for Approval
The FDA has determined that docetaxel injection, 40 mg/mL, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.
Source: Federal Register — Health and Human ServicesOpen original release →